The fabrication of 3D bioconstructs using bioprinters will advance the field of regenerative medicine owing to its ability to facilitate clinical treatments. Additional stimulations have been applied to the bioconstructs to guide cells laden in the bioconstructs. However, the conventional bench-to-bedside delivery based on separate bioprinting and biostimulating processes may increase the risks of contamination and shape discordance owing to the considerably long process involved. In situ bioprinting is aimed at eliminating these risks, but stimulation strategies implied during in situ printing have not yet been extensively reviewed. Here, we present the concept of stimulus-assisted in situ bioprinting, which integrates the printing and biostimulation processes by directly applying stimuli to the bioink during fabrication.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.tibtech.2024.11.001 | DOI Listing |
Methods Mol Biol
January 2025
Bioprinting Laboratories Inc., Dallas, TX, USA.
Human brain organoids (HBOs) derived from pluripotent stem cells hold great potential for disease modeling and high-throughput compound screening, given their structural and functional resemblance to fetal brain tissues. These organoids can mimic early stages of brain development, offering a valuable in vitro model to study both normal and disordered neurodevelopment. However, current methods of generating HBOs are often low throughput and variable in organoid differentiation and involve lengthy, labor-intensive processes, limiting their broader application in both academic and industrial research.
View Article and Find Full Text PDFMethods Mol Biol
January 2025
Department of Biomedical Engineering, University of North Texas, Denton, TX, USA.
Human liver organoids (HLOs) derived from pluripotent stem cells hold potential for disease modeling and high-throughput compound screening due to their architectural and functional resemblance to human liver tissues. However, reproducible, scale-up production of HLOs for high-throughput screening (HTS) presents challenges. These include the high costs of additives and growth factors required for cell differentiation, variability in organoid size and function from batch to batch, suboptimal maturity of HLOs compared to primary hepatocytes, and low assay throughput due to excessive manual processes and the absence of assay-ready plates with HLOs.
View Article and Find Full Text PDFBiofabrication
January 2025
Biomedical Engineering and CÚRAM, SFI Research Centre for Medical Devices, University of Galway, School of Engineering, University Road, Galway, Ireland, Galway, H91 TK33, IRELAND.
Despite significant advances in bioprinting technology, current hardware platforms lack the capability for process monitoring and quality control. This limitation hampers the translation of the technology into industrial GMP-compliant manufacturing settings. As a key step towards a solution, we developed a novel bioprinting platform integrating a high-resolution camera for in-situ monitoring of extrusion outcomes during embedded bioprinting.
View Article and Find Full Text PDFNanomaterials (Basel)
December 2024
Department of Textiles, Faculty of Natural Sciences and Engineering, University of Ljubljana, Aškerčeva 12, 1000 Ljubljana, Slovenia.
A smart viscose fabric with temperature and pH responsiveness and proactive antibacterial and UV protection was developed. PNCS (poly-(N-isopropylakrylamide)/chitosan) hydrogel was used as the carrier of silver nanoparticles (Ag NPs), synthesised in an environmentally friendly manner using AgNO and a sumac leaf extract. PNCS hydrogel and Ag NPs were applied to the viscose fabric by either in situ synthesis of Ag NPs on the surface of viscose fibres previously modified with PNCS hydrogel, or by the direct immobilisation of Ag NPs by the dehydration/hydration of the PNCS hydrogel with the nanodispersion of Ag NPs in the sumac leaf extract and subsequent application to the viscose fibres.
View Article and Find Full Text PDFRegen Biomater
November 2024
Zhejiang Top-Medical Medical Dressing Co. Ltd, Wenzhou, Zhejiang 325025, China.
Decellularization is the process of obtaining acellular tissues with low immunogenic cellular components from animals or plants while maximizing the retention of the native extracellular matrix structure, mechanical integrity and bioactivity. The decellularized tissue obtained through the tissue decellularization technique retains the structure and bioactive components of its native tissue; it not only exhibits comparatively strong mechanical properties, low immunogenicity and good biocompatibility but also stimulates neovascularization at the implantation site and regulates the polarization process of recruited macrophages, thereby promoting the regeneration of damaged tissue. Consequently, many commercial products have been developed as promising therapeutic strategies for the treatment of different tissue defects and lesions, such as wounds, dura, bone and cartilage defects, nerve injuries, myocardial infarction, urethral strictures, corneal blindness and other orthopedic applications.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!